AI Transforms Brain Tumor Diagnostics

Researchers at Mayo Clinic have developed an AI-based approach to classify meningiomas, the most common adult brain tumor, and predict their recurrence risk using standard pathology slides. This method offers a faster, more accessible, and cost-effective alternative to traditional DNA methylation profiling. Concurrently, Mayo Clinic, in collaboration with Princess Margaret Cancer Centre, mapped the tumor microenvironment of meningiomas, revealing how surrounding cells influence tumor behavior and patient outcomes. Separately, researchers at the German Cancer Research Center and University Hospital Heidelberg developed Hetairos, an AI system that can classify over 100 molecular subtypes of central nervous system tumors from routine microscope slides, reducing diagnostic times from weeks to minutes. These advancements promise to revolutionize neuro-oncology diagnostics by providing rapid, accurate, and globally accessible molecular classification, leading to more personalized and effective cancer care.